News
11-07-2011, 08:40 AM
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.
More... (http://www.news-medical.net/news/20111107/NanoString-closes-2420M-Series-D-round-of-equity-financing.aspx)
More... (http://www.news-medical.net/news/20111107/NanoString-closes-2420M-Series-D-round-of-equity-financing.aspx)